From: Effectiveness of potential antiviral treatments in COVID-19 transmission control: a modelling study
Parameter | Description | Unit | Value | Range | Method |
---|---|---|---|---|---|
βii * | Transmission relative rate among age group i | Individuals−1·days−1 | Shown in text |  ≥ 0 | Curve fitting |
βij * | Transmission relative rate from age group i to j | Individuals−1·days−1 | Shown in text |  ≥ 0 | Curve fitting |
βji * | Transmission relative rate from age group j to i | Individuals−1·days−1 | Shown in text |  ≥ 0 | Curve fitting |
βjj * | Transmission relative rate among age group i | Individuals−1·days−1 | Shown in text |  ≥ 0 | Curve fitting |
κ | Relative transmissibility rate of asymptomatic to symptomatic individuals | 1 | 0.65 | 0–1 | |
p | Proportion of the asymptomatic | 1 | 0.36 | 0.016–0.78 | |
ω | Incubation relative rate | days−1 | 0.2 | 0.05556–0.5 | |
ω′ | Latent relative rate | days−1 | 0.2 | 0.05556–0.5 | |
qi*/qj* | Severely rate of symptomatic in age group i/j | 1 | Shown in text |  ≥ 0 | Analysis of data |
γ | Recovered/Removed rate of the symptomatic | days−1 | 0.2 | 0.1111–0.3333 | |
γ′ | Recovered/Removed rate of the asymptomatic | days−1 | 0.1 | 0.04762–1 | |
fci*/ fcj* | Fatality of the disease in age group i/j | 1 | Shown in text |  ≥ 0 | Analysis of data |